NS PEACE NEONATAL EXAM
NS-PEACE
- Condition(s): Other
- Phase: N/A
- Clinicaltrials.gov ID: NA
What is the goal of the study?
To optimize care for neonatal seizures and their consequences, we propose to use observational methods to study (1) the best second-line anti-seizure medication for acute neonatal seizures (phenytoin/fosphenytoin vs levetiracetam), (2) the potential for subsequent chronic use of sodium channel blockers (i.e., oxcarbazepine) to increase the risk for infantile spasms syndrome, and (3) the reliability and validity of our published model to predict epilepsy among neonates with acute symptomatic seizures who survive into infancy. We will conduct this work using the Pediatric Epilepsy Learning Health System, a consortium of US academic pediatric epilepsy programs that work collaboratively to improve outcomes for children with epilepsy through cycles of electronic health record collection and analysis. The proposal aligns with the 2020 Epilepsy Research Benchmarks and will directly inform clinical care for neonates with acute symptomatic seizures, as well as lay the foundation for epilepsy prevention trials.
Who can participate in the study?
Please contact the study team listed below to learn more.
Study Team:
- PI (Study Doctor): Lindsey Morgan
- Study Team Member: Jacqueline Lee-Eng, [email protected]